LONDON (ShareCast) - (Sharecast News) - Trellus Health announced on Wednesday that the 'Trellus Resilience Training and Self-Management Solution' for inflammatory bowel disease was now available on GI OnDemand, a gastroenterology-focussed multidisciplinary virtual integrated care platform.
The AIM-traded firm said GI OnDemand - a joint venture between the American College of Gastroenterology (ACG) and Gastro Girl, now offered the Trellus IBD programme, to all GI OnDemand and ACG members to coordinate and deliver personalised behavioural, emotional and nutritional support for their IBD patients remotely via digital solutions, and access to an expert resilience team via telehealth.

It said the Trellus IBD programme would be the only resilience driven self-management training solution offered via the platform to more than 16,000 gastrointestinal professionals across the United States, for the benefit of the "millions of patients" they collectively serve.

The partnership with GI OnDemand formed a "key part" of Trellus Health's strategy to expand access to its self-management solution through multiple channels, including via healthcare providers and directly to patients, and was expected to prove to be a key channel to market for accessing direct-to-consumer customers.

Trellus said it intended to leverage the data generated on expected improvements in outcomes and on reductions in the cost of caring for gastrointestinal patients, to support the wider rollout of its solution to both private and nationally-funded healthcare payers.

"I am delighted to launch our partnership with GI OnDemand which adds another significant growth channel under our direct-to-consumer model to support the commercialisation of the Trellus IBD self-management programme," said chief executive officer Dr Marla Dubinsky.

"We will be the only resilience training solution offered to this network of over 16,000 US-based gastrointestinal professionals and alongside our licensing agreement with the Crohn's and Colitis Foundation, the largest patient advocacy group for IBD in the US, we have already established the broadest possible reach into the US gastroenterological community, to access both patients and GI providers nationwide."

At 1153 BST, shares in Trellus Health were down 10.38% at 11.65p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE